Amnion

Amnion is a biotechnology company specializing in the development and commercialization of regenerative medicine products derived from human amniotic tissue. The company leverages the unique biological properties of the amniotic membrane, which is rich in growth factors, cytokines, and extracellular matrix proteins, to promote healing and reduce inflammation. Their product portfolio primarily targets ophthalmic, orthopedic, and wound care applications, providing clinicians with advanced biologic solutions for tissue repair. Amnion's proprietary processing techniques ensure the preservation of the tissue's structural integrity and biological activity while maintaining high safety standards. By focusing on the regenerative potential of birth tissues, the company aims to improve patient outcomes in chronic and acute clinical settings.